IMVT (Immunovant Inc) Net Profit

IMVT (Immunovant) - company brandmark

Immunovant, Inc. (IMVT) immunological development is independent of GDP and seasonality, possessing high macro-resilience. On GURU.Markets, the company's net reported profit chart visualizes current revenue volatility, where the value of -0.53 reflects this status. Stable financial health is supported by the momentum of monoclonal antibody research, while strategic alliances with medical centers help create innovative therapies for rare pathologies.

IMVT (Immunovant, Inc.) Net Profit history from 07/04/2022 to 10/31/2026

Analytical breakdowns and data insights for company Immunovant (IMVT)

- price and consensus price forecast:
Stock Quotes Immunovant Therapeutics|IMVT - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Immunovant Therapeutics|IMVT - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Immunovant|IMVT - Book Capitalization|Market Capitalization to Book Value immunovant.com|IMVT - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Immunovant, Inc.|IMVT - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Immunovant Inc|IMVT - Company Total Debt|Debts to Book Capitalization Immunovant Therapeutics|IMVT - Company Long-Term Debt|Company Short-Term Indebtedness Immunovant|Immediate Liquidity immunovant.com
- net income and valuation multiples indicators:
IMVT - Net Profit
Summary company analysis:Immunovant, Inc.
Core merchandise of Immunovant Corp

For Immunovant, Inc. (IMVT), whose success depends on clinical trial outcomes and regulatory drug approval, tracking actual cash flow generation is critical. This result of the company's financial and business operations reflects the daily equity value of earnings, allowing investors to objectively assess the asset's value and avoid overpaying for speculative expectations during periods of high volatility or the emergence of patient side effects.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit KNSA (Kiniksa Pharmaceuticals Ltd)|Net Financial Result Grifols Biemat (GRFS)|ADPT - Company Net Income|celldex.com (CLDX) - Net Income|Aurinia Pharmaceuticals Inc. (AUPH) - Company Net Income|Net Income BioCryst Pharmaceuticals, Inc.|Net Income VERA|Net Profit Dianthus Corp|Company Net Income Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Company Profit|Net Profit TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Company Net Income|Pharming - Net Profit|Net Financial Result Nektar Corp NKTR|Upstream Bio Inc (UPB) - Company Net Income|Net Income zenasbio.com|Company Net Income Immunome|Net Income Gossamer Bio Inc (GOSS)|Net Income KALV (KalVista Pharmaceuticals Inc)|Net Profit Septerna Pharma (SEPN)|Company Net Income Pieris Pharmaceuticals PVLA|SVRA: Company Profit|RIGL - Company Net Income|Company Net Income AnaptysBio Inc|ATXS (Astria Pharma) - Net Income|ENGN (enGene Corp) - Company Net Income|RAPT (RAPT Therapeutics, Inc.) - Net Profit|Net Profit Aerovate|Company Net Income Aclaris Therapeutics, Inc. (ACRS)|Kyverna Therapeutics Inc. - Company Profit|Tiziana Life Sciences PLC - Net Income|Profit After Payment of Taxes CABA (Cabaletta Bio Inc)|VTYX: Net Income|Final Profit THTX (theratech.com)|AVTX: Net Profit|ELDN - Net Financial Result|Company Net Income Agenus Inc|Company Profit CLYM (Climb Bio, Inc)|Net Profit ZURA|Net Income atyrpharma.com ATYR|Adagene Inc. - Net Income|Net Financial Result ImageneBio (IMA)|Shattuck Therapeutics - Net Profit|Net Financial Result Equillium, Inc. EQ|connectbiopharm.com (CNTB) - Company Net Income|Net Income Immunic|Net Income ATRA|Company Net Income IFRX|Net Income XFOR (X4 Pharma)|Profit After Payment of Taxes ACET|Company Net Income Celularity CELU|INMB (inmunebio.com) - Profit After Tax|Barinthus Biotherapeutics plc - Net Profit|Final Profit KZR (Kezar Life Sciences Inc.)|SABS: Net Profit|Akari Therapeutics, Plc (AKTX) - Net Profit|Company Net Income Enlivex Therapeutics Ltd|QTTB: Final Profit|Company Net Income GeoVax (GOVX)|Net Income Edesa Biotech Inc EDSA|Net Profit IBIO (iBio Corp)|Net Profit Carisma Therapeutics Inc CARM|XTLB: Net Income|Final Profit BOLT (Bolt Biotherapeutics)|HCWB: Net Profit|APVO - Net Financial Result|Company Net Income AIM ImmunoTech|Net Income Aditxt Corp (ADTX)|Company Net Income GRI Bio, Inc. (GRI)|Net Income xortx.com XRTX|Vyome Holdings - Net Income|Net Profit Revelation Biosciences Inc REVB|INDP - Company Net Income|SCNI (BiondVax Pharmaceuticals) - Company Profit|CALI: Net Profit|Company Net Income Affimed N.V. (AFMD)|ALLK (Allakos Inc) - Net Profit|HOOKIPA (HOOK) - Net Financial Result|Company Net Income IGM Biosciences, Inc. (IGMS)|Net Income iTeos Pharma ITOS|Company Net Income Ocean Biomedical, Inc. OCEA|TCBP - Net Income|THRD: Net Income